Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Van Damme

Showing results (1-10 of 417) with videos related to

Pageof 42
Sort By:
The Journal of Infectious Diseases|January 24, 2016
Long-term Protection After Hepatitis B VaccinePierre Van Damme
Acta Gastro-Enterologica Belgica|November 19, 2003
Long-term protection after hepatitis A and B vaccination: an updatePierre Van Damme
Vaccine|December 13, 2003
Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adultsPierre Van Damme, Margaret Burgess
Scandinavian Journal of Infectious Diseases|November 18, 2009
Age distribution of paediatric rotavirus gastroenteritis cases in Europe: the REVEAL studyCarlo Giaquinto, Pierre van Damme,
Vaccine|July 26, 2016
Re: Letter to the Editor: P. van Damme et al., Vaccine 34 (2016) 757-761, as a reply to Ryser et al's letter in VaccinePierre Van Damme, Margaret Stanley
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2011
Hepatitis B and the need for a booster doseElke Leuridan, Pierre Van Damme
Expert Opinion on Drug Delivery|August 19, 2010
Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccinesVanessa Vankerckhoven, Pierre Van Damme
Lancet (London, England)|February 13, 2007
Effectiveness of seven-valent pneumococcal conjugate vaccinePhilippe Beutels, Pierre Van Damme
Vaccine|July 25, 2018
HPV immunization programs: Ensuring their sustainability and resilienceAlex Vorsters, Pierre Van Damme
Journal of Medical Virology|July 13, 2002
Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001Pierre Van Damme, Alex Vorsters
Pageof 42

Showing results (1-10 of 417) with videos related to

Sort By:
Pageof 42
The Journal of Infectious Diseases|January 24, 2016
Long-term Protection After Hepatitis B VaccinePierre Van Damme
Acta Gastro-Enterologica Belgica|November 19, 2003
Long-term protection after hepatitis A and B vaccination: an updatePierre Van Damme
Vaccine|December 13, 2003
Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adultsPierre Van Damme, Margaret Burgess
Scandinavian Journal of Infectious Diseases|November 18, 2009
Age distribution of paediatric rotavirus gastroenteritis cases in Europe: the REVEAL studyCarlo Giaquinto, Pierre van Damme,
Vaccine|July 26, 2016
Re: Letter to the Editor: P. van Damme et al., Vaccine 34 (2016) 757-761, as a reply to Ryser et al's letter in VaccinePierre Van Damme, Margaret Stanley
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2011
Hepatitis B and the need for a booster doseElke Leuridan, Pierre Van Damme
Expert Opinion on Drug Delivery|August 19, 2010
Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccinesVanessa Vankerckhoven, Pierre Van Damme
Lancet (London, England)|February 13, 2007
Effectiveness of seven-valent pneumococcal conjugate vaccinePhilippe Beutels, Pierre Van Damme
Vaccine|July 25, 2018
HPV immunization programs: Ensuring their sustainability and resilienceAlex Vorsters, Pierre Van Damme
Journal of Medical Virology|July 13, 2002
Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001Pierre Van Damme, Alex Vorsters
Pageof 42